Rajkumar Kannan occupies the position of Chief Executive Officer & Director at Aerie Pharmaceuticals, Inc.

He is also on the board of Amryt Pharma Holdings Ltd. and Amryt Pharma Plc.

In the past he held the position of Global Head-Neurology & Immunology at Merck KGaA, Chief Commercial Officer for Kiniksa Pharmaceuticals Ltd., President, Chief Executive Officer & Director at Chiasma, Inc. and Head-Cardiovascular Franchise Global Marketing at Boehringer Ingelheim Corp.

Rajkumar Kannan received an MBA from East Carolina University and an undergraduate degree from the University of Madras.